Assyro AI

FDA PDUFA dates in May 2026

Published PDUFA target action dates for NDAs, BLAs, ANDAs, and INDs scheduled in May 2026, sourced from FDA primary records.

Tracking 5 published FDA PDUFA decisions, including 1 NDA and 4 BLAs.

FDA PDUFA dates in May 2026: 5 published FDA PDUFA target action dates.
SponsorProductTypeApplicationPDUFA dateStatus
argenxVYVGARTBLAPENDING-provisional|argenx|vyvgart|achrabseronegativegenoverdue
Daiichi Sankyo and AstraZenecaENHERTU followed by THPBLAPENDING-provisional|daiichisankyoandastrazeneca|enhertufoverdue
Eisai and BiogenLEQEMBI IQLIKBLAPENDING-provisional|eisaiandbiogen|leqembiiqlik|subcutanoverdue
MannKindAfrezzaBLAPENDING-provisional|mannkind|afrezza|diabetesinchildrenaupcoming
CingulateCTx-1301NDAPENDING-provisional|cingulate|ctx1301|attentiondeficithyupcoming

Use the calendar, timeline, status board, or table views above to filter, sort, and inspect source-linked details.

May 2026 FDA PDUFA Calendar: Drug Approval Dates & Deadlines

Track May 2026 FDA PDUFA dates for NDA, BLA, ANDA, and IND decisions. Free drug approval tracker with source-linked deadlines, calendar views, and daily updates.